drugset / Trial / NCT03283670
Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies
Phase 2
Completed
24 enrolled
Washington University School of Medicine
Brain & Behavior Research Foundation · collab
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of the study aims to determine whether different concentrations of nitrous oxide (N2O) have different antidepressant effects for adults with treatment-resistant major depression.
Timeline
- Start
- 2016-11-22
- Primary completion
- 2020-02-18
- Completion
- 2020-02-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitrous Oxide | Other / unclassified | 25 % | Inhaled |
| Subject | Nitrous Oxide | Other / unclassified | 50 % | Inhaled |